Keyphrases
Tumor
100%
Tumor Acidity
100%
Breast Cancer Patients
100%
Early Phase Clinical Trials
100%
MRI Scan
42%
Early Response
28%
Non-invasive Imaging
28%
Clinical Trials
28%
Daily Treatment
14%
Acidosis
14%
Lymphoma Model
14%
Drug Treatment
14%
Paclitaxel
14%
Tumor Hypoxia
14%
MRI Methods
14%
MTOR Inhibitor
14%
Chemical Exchange Saturation Transfer Imaging
14%
Tumor Subtype
14%
Hypoxia
14%
Extracellular pH
14%
Preclinical Imaging
14%
Glycolysis
14%
Specific Intent
14%
Response to Neoadjuvant Chemotherapy
14%
Imaging Results
14%
Parametric Maps
14%
Everolimus
14%
3T MRI
14%
Tumor Model
14%
Neoadjuvant Chemotherapy
14%
Doxorubicin-cyclophosphamide
14%
Tumor Growth Delay
14%
Dose-dense
14%
Carbonic Anhydrase IX
14%
Response to Chemotherapy
14%
High-level Expression
14%
Patient with Tumor
14%
IRB Protocol
14%
Aggressive Tumor
14%
Clinical Outcomes
14%
Medicine and Dentistry
Breast Cancer
100%
Clinical Trial
100%
Magnetic Resonance Imaging
100%
Acidosis
100%
Neoplasm
100%
Tumor Imaging
100%
Clinical Study
20%
Ex Vivo
20%
Neoadjuvant Chemotherapy
20%
Magnetic Resonance Imaging
10%
Tumor Hypoxia
10%
Biological Marker
10%
Paclitaxel
10%
Hypoxia
10%
Mammalian Target of Rapamycin Inhibitor
10%
Cyclophosphamide
10%
Everolimus
10%
Volunteer
10%
Carbonate Dehydratase IX
10%
Preclinical Imaging
10%
Dose Densification
10%
Tumor Progression
10%
Drug Therapy
10%
Chemical Exchange Saturation Transfer
10%
Doxorubicin
10%
Tumor Model
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Breast Cancer
100%
Clinical Trial
100%
Chemotherapy
25%
Hypoxia
16%
Everolimus
8%
Cyclophosphamide
8%
Doxorubicin
8%
Biological Marker
8%
Tumor Model
8%
Mammalian Target of Rapamycin Inhibitor
8%
Paclitaxel
8%
Pharmacotherapy
8%
Tumor Growth
8%
Clinical Study
8%
Preclinical Study
8%
Carbonate Dehydratase IX
8%